Lizong Shen

2.5k total citations
52 papers, 1.9k citations indexed

About

Lizong Shen is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Lizong Shen has authored 52 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 22 papers in Oncology and 19 papers in Surgery. Recurrent topics in Lizong Shen's work include Gastric Cancer Management and Outcomes (12 papers), Helicobacter pylori-related gastroenterology studies (11 papers) and Cancer Cells and Metastasis (8 papers). Lizong Shen is often cited by papers focused on Gastric Cancer Management and Outcomes (12 papers), Helicobacter pylori-related gastroenterology studies (11 papers) and Cancer Cells and Metastasis (8 papers). Lizong Shen collaborates with scholars based in China, United States and Ireland. Lizong Shen's co-authors include Jing Zhai, Shoulin Wang, Jiajia Shen, Yangchun Zhou, Ming‐Fang He, Xuequan Yao, Hao Xu, Jiaqi Wu, Zhihong Zhang and Jian‐Ping Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Oncogene.

In The Last Decade

Lizong Shen

51 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lizong Shen China 26 1.0k 670 471 429 415 52 1.9k
Jianjun He China 27 940 0.9× 837 1.2× 846 1.8× 286 0.7× 433 1.0× 86 2.2k
Haiyong Wang China 27 867 0.9× 550 0.8× 477 1.0× 327 0.8× 370 0.9× 83 1.8k
Hao Wen China 26 981 1.0× 453 0.7× 517 1.1× 279 0.7× 274 0.7× 103 2.1k
Eiji Kashiwagi Japan 31 1.3k 1.2× 628 0.9× 588 1.2× 565 1.3× 943 2.3× 126 2.6k
Yoshiro Itatani Japan 23 865 0.9× 1.1k 1.6× 524 1.1× 236 0.6× 283 0.7× 72 2.1k
Bo Kong Germany 25 1.0k 1.0× 899 1.3× 740 1.6× 290 0.7× 211 0.5× 64 2.0k
Dunfa Peng United States 32 1.7k 1.7× 689 1.0× 657 1.4× 627 1.5× 491 1.2× 87 2.6k
Martin G. Dalin Sweden 12 778 0.8× 749 1.1× 361 0.8× 310 0.7× 206 0.5× 14 1.7k
Stefano Caruso France 28 969 1.0× 471 0.7× 687 1.5× 198 0.5× 330 0.8× 55 1.9k
Hirokazu Okayama Japan 30 1.3k 1.3× 962 1.4× 721 1.5× 242 0.6× 392 0.9× 92 2.4k

Countries citing papers authored by Lizong Shen

Since Specialization
Citations

This map shows the geographic impact of Lizong Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lizong Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lizong Shen more than expected).

Fields of papers citing papers by Lizong Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lizong Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lizong Shen. The network helps show where Lizong Shen may publish in the future.

Co-authorship network of co-authors of Lizong Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Lizong Shen. A scholar is included among the top collaborators of Lizong Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lizong Shen. Lizong Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Jia, et al.. (2025). The profiles of immunosuppressive microenvironment in the Lauren intestinal-type gastric adenocarcinoma. Cancer Immunology Immunotherapy. 74(3). 82–82. 2 indexed citations
2.
Li, Fangyuan, Yaohui Wang, Jiani C. Yin, et al.. (2024). Molecular evolution of intestinal-type early gastric cancer according to Correa cascade. Journal of Biomedical Research. 39(3). 270–270. 3 indexed citations
3.
Wang, Yaohui, Tiancheng Zhang, Fangyuan Li, et al.. (2023). Neutrophils promote tumor invasion via FAM3C-mediated epithelial-to-mesenchymal transition in gastric cancer. International Journal of Biological Sciences. 19(5). 1352–1368. 22 indexed citations
4.
Li, Xiang, Jing Zhai, Tiancheng Zhang, et al.. (2022). Tumor-derived IL-8 facilitates lymph node metastasis of gastric cancer via PD-1 up-regulation in CD8+ T cells. Cancer Immunology Immunotherapy. 71(12). 3057–3070. 34 indexed citations
5.
Wu, Jiaqi, Jing Zhai, Chong-Yong Li, et al.. (2022). Docetaxel and 5-FU enhanced the inhibitory effects of apatinib and ramucirumab on growth and migration of gastric cancer. Life Sciences. 296. 120439–120439. 6 indexed citations
6.
Liu, Xia, Celine L. Hartman, Lingyun Li, et al.. (2021). Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy. Science Translational Medicine. 13(587). 200 indexed citations
7.
Zhai, Jing, Jiaqi Wu, Yaohui Wang, et al.. (2021). Prediction of Sensitivity and Efficacy of Clinical Chemotherapy Using Larval Zebrafish Patient-Derived Xenografts of Gastric Cancer. Frontiers in Cell and Developmental Biology. 9. 680491–680491. 11 indexed citations
9.
Wang, Yaohui, Jing Zhai, Tiancheng Zhang, et al.. (2020). Tumor-Associated Neutrophils Can Predict Lymph Node Metastasis in Early Gastric Cancer. Frontiers in Oncology. 10. 570113–570113. 34 indexed citations
10.
Gao, Cheng, et al.. (2019). Long non-coding RNA SNHG17 promotes gastric cancer progression by inhibiting P15 and P16. Translational Cancer Research. 8(2). 520–531. 1 indexed citations
11.
Zhai, Jing, Jiajia Shen, Jiaqi Wu, et al.. (2019). Cancer-associated fibroblasts-derived IL-8 mediates resistance to cisplatin in human gastric cancer. Cancer Letters. 454. 37–43. 206 indexed citations
13.
Gao, Cheng, Liuhua Wang, Guoxin Zhang, et al.. (2018). Involvement of Aryl Hydrocarbon Receptor and Aryl Hydrocarbon Receptor Repressor in Helicobacter Pylori-related Gastric Pathogenesis. Journal of Cancer. 9(15). 2757–2764. 11 indexed citations
14.
Wu, Jiaqi, Jing Zhai, Chong-Yong Li, et al.. (2017). Patient-derived xenograft in zebrafish embryos: a new platform for translational research in gastric cancer. Journal of Experimental & Clinical Cancer Research. 36(1). 160–160. 68 indexed citations
15.
Zhou, Yangchun, Yao Wang, Shoulin Wang, & Lizong Shen. (2015). Hyperglycemia Promotes Human Gastric Carcinoma Progression via Aquaporin 3. Digestive Diseases and Sciences. 60(8). 2338–2345. 17 indexed citations
16.
Qian, Yingying, Dong Pei, Jiali Xu, et al.. (2014). The XPD Lys751Gln Polymorphism has Predictive Value in Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy: a Systemic Review and Meta-analysis. Asian Pacific Journal of Cancer Prevention. 15(22). 9699–9706. 7 indexed citations
17.
Gao, Fei, et al.. (2014). Incidence of Microscopically Positive Proximal Margins in Adenocarcinoma of the Gastroesophageal Junction. PLoS ONE. 9(2). e88010–e88010. 7 indexed citations
18.
Zhao, Lianying, et al.. (2012). Diabetes Mellitus and the Incidence of Colorectal Cancer: An Updated Systematic Review and Meta-Analysis. Digestive Diseases and Sciences. 57(6). 1576–1585. 161 indexed citations
19.
Gao, Fei, et al.. (2012). Involvement of Aquaporin 3 in Helicobacter pylori-Related Gastric Diseases. PLoS ONE. 7(11). e49104–e49104. 26 indexed citations
20.
Wang, Jianping, et al.. (2012). c-Met upregulates aquaporin 3 expression in human gastric carcinoma cells via the ERK signalling pathway. Cancer Letters. 319(1). 109–117. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026